Loading insider details...
Latest Form 4 (Jun 22, 2026): Sale of 1,776 NKTX shares, $4.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Nkarta, Inc. (NKTX) | Sale | 1,776 | $4.8K |
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| Jan 20, 2026 | Nkarta, Inc. (NKTX) | Sale | 26,046 | $53.9K |
| Jan 8, 2026 | Nkarta, Inc. (NKTX) | Grant/Award | 94,000 | n/a |
| Jun 20, 2025 | Nkarta, Inc. (NKTX) | Sale | 1,790 | $3.2K |
| Jun 16, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 22,500 | n/a |
| Jun 9, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 377,000 | n/a |
| Jan 17, 2025 | Nkarta, Inc. (NKTX) | Sale | 17,378 | $38.2K |
| Jan 7, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 94,500 | n/a |
| Jun 20, 2024 | Nkarta, Inc. (NKTX) | Sale | 1,770 | $9.9K |